Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.38% | 6.68% | -105.50% | 2,537.93% | -13.62% |
| Total Depreciation and Amortization | 113.41% | -36.41% | 19.76% | 33.96% | 39.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.35% | -1,125.01% | -88.25% | 11,038.78% | 125.31% |
| Change in Net Operating Assets | -152.53% | 417.46% | -81.23% | 44.28% | -237.94% |
| Cash from Operations | 36.52% | -133.82% | -105.36% | 1,933.68% | -174.00% |
| Capital Expenditure | 41.51% | -359.95% | 41.58% | -15.43% | -403.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.72% | 58.34% | 44.05% | -401.37% | 210.52% |
| Cash from Investing | 69.40% | 56.56% | 44.04% | -405.87% | 209.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.45% | -10.45% | -22.31% | -10.70% | 12.78% |
| Issuance of Common Stock | -93.98% | 775.66% | -92.99% | 802.93% | 3,603.70% |
| Repurchase of Common Stock | -- | -- | 77.51% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -174.08% | 113.52% | 73.97% | -33,292.49% | 78.56% |
| Foreign Exchange rate Adjustments | 608.65% | -91.14% | 165.29% | -5,917.67% | -181.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.63% | -9.27% | -120.24% | 13,849.22% | 1,243.50% |